Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c80 |
|---|---|
| Identifier | NCT07216014 |
| Trial Title | Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease and Ulcerative Colitis |
| Interventions | DRUG: Interleukin 23|DEVICE: Interleukin 23 |
Participant Information
| Sponsor | Sixth Affiliated Hospital, Sun Yat-sen University |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-12-01 |
|---|---|
| Primary Completion Date | 2026-09-30 |
| Completion Date | 2026-10-10 |